Find uplifting stories about heroes, innovations, and solutions
3976 results for "sickle cell cure"
A new stem cell transplant developed at Johns Hopkins has cured sickle cell disease in 95% of patients, using half-matched donors like parents or siblings. The breakthrough means nearly every sickle cell patient can now access a cure that also preserves fertility.
A New Jersey teen became the first patient in the state to be cured of sickle cell disease using his own genetically modified cells, eliminating the need for a donor. The breakthrough offers hope to thousands who lack family matches.
Physicians have reached a remarkable 95% cure rate for sickle cell disease using bone marrow transplants, offering new hope to millions living with this painful genetic condition. This breakthrough represents a major leap forward in treating a disease that has long been considered incurable.
Scientists are calling new gene editing treatments a potential "functional cure" for sickle cell disease, offering hope to millions. Early results show patients living pain-free after a single treatment.
Daniel Cressy just became the first person on the Gulf Coast functionally cured of sickle cell disease through gene therapy, clearing the path to his dream of becoming a commercial pilot. His groundbreaking treatment offers new hope for Louisiana, which has the highest rate of sickle cell disease in America.
A Louisiana man just became the first person in the state to be functionally cured of sickle cell disease using advanced gene therapy. The breakthrough offers hope to thousands living with the painful genetic blood disorder.
After decades of research, gene therapy is bringing lasting relief to sickle cell patients after just one treatment. UCLA researchers are leading the charge to cure a disease that affects 100,000 Americans.
A 23-year-old aspiring pilot from New Orleans has become the first person in Louisiana functionally cured of sickle cell disease through groundbreaking gene therapy. Daniel Cressy can now pursue his aviation dreams and help others through his nonprofit.
Jessica Ceja became the first person in Maryland to receive groundbreaking gene therapy that could cure her lifelong sickle cell disease. Her own cells were reengineered in a lab to produce healthy red blood cells, potentially ending decades of pain.
A 41-year-old mother who spent her life battling sickle cell disease just became the first adult in Maryland to receive a potentially curative gene therapy using her own cells. After decades of hospital stays and missing family moments, Jessica Ceja now has hope for a life without the painful disease.
Daniel Cressy just became the first person in Louisiana to be functionally cured of sickle cell disease, and now he's determined to help others access the same life-changing treatment. After a grueling two-year gene therapy journey, the 23-year-old from New Orleans is launching a nonprofit to ensure zip code doesn't determine who gets cured.
A breakthrough gene editing treatment has achieved what doctors call a "functional cure" for sickle cell disease, with 27 out of 28 patients experiencing zero painful crises after receiving the therapy. The one-time treatment edits patients' own blood cells to correct the genetic mutation, offering new hope for 100,000 Americans living with this painful disease.
Two scientists just won a $3 million prize for discovering how to switch on healthy blood cells in people with sickle cell disease. Their breakthrough has led to gene therapies that functionally cure patients who once faced lifelong pain.
Daniel Cressy, 23, has become the first person in Louisiana to be functionally cured of sickle cell disease using groundbreaking gene therapy. His treatment gives hope to over 100,000 Americans living with the painful blood disorder.
Daniel Cressy became the first person in the Gulf South to be functionally cured of sickle cell disease through gene therapy. The 23-year-old from Louisiana can now pursue his dream of becoming a pilot after the FAA previously denied him due to his condition.
Samuel Idahosa, 24, endured monthly hospitalizations and excruciating pain from sickle cell disease since childhood. After receiving groundbreaking gene therapy at UCLA Health in 2025, he's now considered cured.
Since the world's first gene-edited therapy for sickle cell disease won approval, scientists are tackling an urgent new challenge: making these cures simpler, safer, and available to everyone who needs them. Seven innovative companies are leading the charge to transform a $2.2 million treatment into something far more practical.
The FDA just approved a groundbreaking gene-editing treatment that can cure sickle cell disease in children as young as two years old. A Nashville doctor who performed the world's first procedure in 2019 is now giving families hope after decades of painful, life-threatening complications.
A groundbreaking gene therapy trial has achieved what doctors call a "functional cure" for sickle cell disease, eliminating painful crises in 27 out of 28 patients. The one-time treatment uses gene editing to fix the blood disorder that has killed patients decades too soon.
A Ugandan biotech firm just received a U.S. patent for a gene therapy that could treat sickle cell disease for 95% less than current cures. The breakthrough could finally bring life-saving treatment to 20 million patients worldwide who can't afford existing options.
Showing 20 of 3976